Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
58 hedge funds and large institutions have $215M invested in Syneron Medical Ltd in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.
467% more call options, than puts
Call options by funds: $17K | Put options by funds: $3K
25% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 16
1% less capital invested
Capital invested by funds: $218M → $215M (-$2.45M)
6% less funds holding
Funds holding: 62 → 58 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$5.61M |
| 2 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
+$2.33M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.96M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$852K |
| 5 |
VAM
Visium Asset Management
New York
|
+$561K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$3.6M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$1.81M |
| 3 |
SAM
Steinberg Asset Management
New York
|
-$1.48M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$876K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$674K |
ELOS Hedge Fund Activity: Q3 2013 in Review
58 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2013, worth a combined $215M — down 1.1% from $218M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ELOS and 4 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 20 added.
The largest buyer was North Tide Capital, adding an estimated $5.61M. The largest seller was Paradigm Capital Management Inc, cutting an estimated $3.6M.
- 58 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2013, down from 62 in Q2 2013.
- Funds reported $215M of Syneron Medical Ltd stock for Q3 2013, down 1.1% quarter-over-quarter.
- 4 funds opened new Syneron Medical Ltd positions in Q3 2013 and 8 closed out, a net change of -4 holders.
- The largest Syneron Medical Ltd buyer in Q3 2013 was North Tide Capital, an estimated $5.61M added.
- The largest Syneron Medical Ltd seller in Q3 2013 was Paradigm Capital Management Inc, an estimated $3.6M sold.
Based on aggregated 13F filings for Q3 2013.